Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Nanotheranostics
ISSN 2206-7418 · Ivyspring International Publishers · Australia
Nanotheranostics: fully open access; APC charged, amount not published; median 94 days to acceptance (35 articles, last 24 months); 18 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Nanotheranostics is published by Ivyspring International Publishers. By OpenAlex counts of its recent articles, its largest topics are Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics and RNA Interference and Gene Delivery, together about 48.6% of its articles. Its main subfields are Biomedical Engineering. (generated from OpenAlex topic counts and CAS ranking data)
Nanotheranostics is an innovative, dynamic and fast-growing field, with cutting-edge technologies emerging from many aspects of medical and clinical research. The number of publications in nanotechnology related to theranostics has increased rapidly. A journal dedicated to theranostics in the nanotechnology space is not only warranted but also necessary to serve the growing scientific community. The aim of Nanotheranostics is to provide a forum for the exchange of clinical and scientific information to make use of “nanotechnology” for diagnostics and therapy of different diseases. Nanotheranostics publishes innovative and original basic, translational and clinical research reflecting the fields of nanomedicine, nanoimaging, drug and gene delivery, nanoelectronic biosensors, and other areas. Regular features include high quality research articles, reviews or mini-reviews, rapid communication of preliminary data on innovative research, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical studies or ethical issues of nanomedicine are also welcome. Timely reviews that provide updates on current applications and issues in nanomedicine and translational aspects of nanotheranostics and other topics are particularly welcome and will be given high priority. Nanotheranostics employs a rigorous peer-review system, but also strives for rapid review turnaround times and is based on the same streamlined submission platform as Theranostics.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Editor-in-chief Jonathan LovellPublisher website
Editorial board by country: 6 in mainland China (about 21%); most named United States 15, Mainland China 6, Hong Kong, China 1, Japan 1, South Korea 1 (28 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nanoparticle-Based Drug DeliveryMaterials Science22.4%
- Nanoplatforms for cancer theranosticsEngineering21.2%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology5%
- Gold and Silver Nanoparticles Synthesis and ApplicationsMaterials Science4.6%
- Ultrasound and Hyperthermia ApplicationsEngineering4.6%
- Photodynamic Therapy Research StudiesMedicine4.5%
- Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology3.4%
- Radiopharmaceutical Chemistry and ApplicationsMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | Q1 | 1/57 | 99th |
| Medicine (miscellaneous) | Q1 | 17/466 | 96th |
| Biotechnology | Q1 | 21/325 | 93rd |
| Biomedical Engineering | Q1 | 25/342 | 92nd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 16.3LetPub ·
- SJR 2026-06
- 1.11LetPub ·
- SJR (publisher)
- 1.2Publisher website ·
- SNIP 2026-06
- 1.09LetPub ·
- h-index
- 49OpenAlex ·
- i10-index
- 208OpenAlex ·
- 2-year mean citedness
- 7.88OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year (publisher)
- 10Publisher website ·
Articles by year OpenAlex count · 291 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 20 | 20 | 1,159 |
| 2025 | 18 | 18 | 1,534 |
| 2024 | 29 | 29 | 1,511 |
| 2023 | 32 | 32 | 1,250 |
| 2022 | 26 | 26 | 970 |
| 2021 | 47 | 47 | 788 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
94 daysMedian, submission to acceptance · P25–P75 62 days – 128 days
- Acceptance to online
- median 24 days (33 articles)
- Submission to online
- median 136 days
- Sample
- 33 articles with submission and acceptance dates (0 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | AUD 750 | No | CC BY | |
| OpenAlex | AUD 1,000 | — | — | |
| LetPub | AUD 1,000 | No | — | |
| Publisher website | AUD 750 | — | — |
Other charges and waivers (author guidelines)
- Other fees
- No other fees
- Submission fee
- AUD 750
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Keywords
- ≥ 3
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Required
- Graphical abstract
- Required
- Cover letter
- Required
- Not considered
- case reports
Article types accepted5
- erratumResearch paper/ Review/ Erratum/ Others $AUD 750 *Length not stated
- othersResearch paper/ Review/ Erratum/ Others $AUD 750 *Length not stated
- research paperResearch paper/ Review/ Erratum/ Others $AUD 750 *Length not stated
- reviewResearch paper/ Review/ Erratum/ Others $AUD 750 *Length not stated
- review articleA well-written review should provide an authoritative and in-depth understanding of key topics in medicine, offering a high-quality, state-of-the-art account of…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Peer review, Plagiarism, Preprints
- Authorship Authorship
Each author listed on a manuscript submitted to this journal must adhere to the four authorship criteria set by the International Committee of Medical Journal Editors (ICMJE): Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND Drafting the work or revising it critically for important intellectual content; AND…
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Competing interests (also known as "conflicts of interest") that may influence the objective presentation of research findings should be disclosed in a paragraph titled "Competing Interests," placed after the Acknowledgments section and before the References. According to the International Committee of Medical Journal Editors, financial relationships—such as employment, consultancies, stock owners…
Source ↗Publisher website ·- Data availability Data Availability
Authors are recommended to deposit large datasets in a public repository. Smaller datasets may be published as supplementary materials. Authors may provide the following: The location and method for accessing the data. If all data are included in the manuscript or supplementary materials, please specify. If the data will be shared upon request, provide detailed contact information. If the data are…
Source ↗Publisher website ·- Publication ethics Publication Ethics
Follows COPE guidelines for publication ethics. Model summary
Our journals follow the guidelines set by the Committee on Publication Ethics (COPE) for addressing publication ethics issues. For more details, please visit our dedicated Publication Ethics page.
Source ↗Publisher website ·- License & copyright License
License: CC BY 4.0 for articles on/after June 10, 2019; authors retain copyright; earlier articles generally CC BY-NC 4.0 with publisher copyright. Model summary
Unless otherwise stated in the individual article, articles published on or after June 10, 2019 are distributed under the Creative Commons Attribution 4.0 International Licence (CC BY 4.0), subject to these Terms of Use. Authors retain copyright of their articles. Articles published before June 10, 2019 were generally distributed under the Creative Commons Attribution-NonCommercial 4.0 Internation…
Source ↗Publisher website ·- Peer review Peer Review
Submitted manuscripts are reviewed for originality, significance, adequacy of documentation, composition, and adherence to these guidelines. However, editorial decisions are based not only on the technical merits of the work but also on factors such as priority for publication and relevance to the general readership of Nanotheranostics. All manuscripts are judged in relation to other submissions c…
Source ↗Publisher website ·- Plagiarism
Zero-tolerance plagiarism policy; screening before, during, and after publication. Model summary
Our journal upholds a zero-tolerance policy toward plagiarism, including self-plagiarism. Manuscripts are screened for plagiarism at all stages—before, during, and after publication.
Source ↗Publisher website ·- Preprints
Preprint policy: preprint-posted manuscripts may be submitted; accepted manuscripts may be posted to other preprint servers. Model summary
Manuscripts previously posted on preprint servers (e.g., BioRxiv, MedRxiv, ChemRxiv) may be submitted to our journal.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Ivyspring International Publishers
- Country or region
- Australia
- Language
- English
- ISSN
- 2206-7418
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Nanotheranostics
How long does peer review take at Nanotheranostics?
Based on the dates recorded on 35 articles published between November 2024 and November 2026 (the last 24 months), the median time from submission to acceptance is 94 days (interquartile range 62–124 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Nanotheranostics?
According to the journal's author guidelines: Keywords: ≥ 3; Reference style: Numbered, in order of citation; Suggested reviewers: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Nanotheranostics based?
Of the 28 board members whose country the journal's board page names, 6 (about 21%) are in mainland China; the countries named most often are United States (15), Mainland China (6) and Hong Kong, China (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Nanotheranostics?
According to LetPub and DOAJ records, Nanotheranostics is indexed in Scopus and DOAJ. The journal's website also lists Web of Science; that list has not been checked against each database.
Is Nanotheranostics open access, and what is the APC?
Nanotheranostics is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .